scholarly journals Accuracy of the Hospital Anxiety and Depression Scale for Identifying Depression in Chronic Obstructive Pulmonary Disease Patients

2014 ◽  
Vol 2014 ◽  
pp. 1-7 ◽  
Author(s):  
Christoph Nowak ◽  
Noriane A. Sievi ◽  
Christian F. Clarenbach ◽  
Esther Irene Schwarz ◽  
Christian Schlatzer ◽  
...  
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Diagnostic Accuracy ◽  
Pulmonary Disease ◽  
Depression Scale ◽  
Anxiety And Depression ◽  
Chronic Obstructive ◽  
Hospital Anxiety ◽  
Obstructive Pulmonary Disease ◽  
Copd Patients ◽  
Clinical Records

Psychological morbidity is common in chronic respiratory diseases. The diagnostic accuracy of the Hospital Anxiety and Depression Scale (HADS) and risk factors for comorbid depression in chronic obstructive pulmonary disease (COPD) are addressed. Consecutive COPD patients (GOLD stage I–IV, 40–75 years old) were enrolled in a multicentre, cross-sectional cohort study. Diagnosis of depression was ascertained through clinical records. Lung function, HADS score, 6-minute walking test (6-MWT), MRC dyspnoea score, and COPD Assessment Test (CAT) were evaluated. Two hundred fifty-nine COPD patients (mean age 62.5 years; 32% female; mean FEV1 48% predicted) were included. Patients diagnosed with depression (29/259; 11.2%) had significantly higher HADS-D and HADS-Total scores than nondepressed patients (median (quartiles) HADS-D 6 [4; 9] versus 4 [2; 7], median HADS-Total 14 [10; 20] versus 8 [5; 14]). Receiver-operating characteristic plots showed moderate accuracy for HADS-D, AUC 0.662 (95%CI 0.601–0.719), and HADS-Total, AUC 0.681 (95%CI 0.620–0.737), with optimal cut-off scores of >5 and >9, respectively. Sensitivity and specificity were 62.1% and 62.6% for HADS-D compared to 75.9% and 55.2% for HADS-Total. Age, comorbidities, sex, and lower airflow limitation predicted depression. The HADS exhibits low diagnostic accuracy for depression in COPD patients. Younger men with comorbidities are at increased risk for depression.

scholarly journals Effect of Inspiratory Muscle Training on Anxiety and Depression in Patient with COPD that Received Pursed Lip Breathing ABSTRACT

2021 ◽  
Vol 9 (2) ◽  
pp. 19-26
Author(s):  
Yeanita ◽  
Rahmi Isma AP
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Depression Scale ◽  
Anxiety And Depression ◽  
Control Group ◽  
Chronic Obstructive ◽  
Hospital Anxiety ◽  
Muscle Training ◽  
Obstructive Pulmonary Disease ◽  
Experimental Group

ABSTRACTIntroduction: The presence of anxiety and depression in patients with Chronic Obstructive Pulmonary Disease (COPD) is often associated with greater disability, higher rates of exacerbations, increasedhospitalization and mortality. Many types of breathing exercises, such as Pursed Lips Breathing (PLB), Diaphragmatic Breathing (DBE), Respiratory Muscle Training (RMT), have been reported positivephysiological effects to reduces breathlessness, anxiety and depression in patients with COPD. This study aims to determine the effect in anxiety and depression after intervention of Inspiratory MuscleTraining (IMT) in COPD patients that received PLB.Methods: An experimental pre and post randomly study design, in August – September 2019. Control group and experimental group each performed PLB exercises while the experimental group got additionalIMT. To evaluate anxiety and depression status, Hospital Anxiety and Depression Scale (HADS) was used.Results: Twenty subjects with COPD were recruited, no significant differences of HADS score between both groups. After 6 weeks of intervention, the HADS score in each group decreased significantly, withdelta of HADS score in experimental group was greater than the control group (p<0.05).Conclusion: Improvement of HADS scores after additional IMT was better than PLB only in COPD patients.Keywords: chronic obstructive pulmonary disease; hospital anxiety and depression scale; inspiratory muscle training; pursed lips breathing.

scholarly journals Prevalence of Anxiety and Depression in Patient with Chronic Obstructive Pulmonary Disease

2018 ◽  
Vol 20 (4) ◽  
pp. 155-162
Author(s):  
Sita Sharma ◽  
U. Shakya ◽  
B. Gorkhali ◽  
S. Neupane
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Psychiatric Symptoms ◽  
Depression Scale ◽  
University Teaching ◽  
Anxiety And Depression ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Copd Patients ◽  
The Impact

Anxiety and depression are very common comorbidities in patients with chronic obstructive pulmonary disease (COPD). This study was aimed at documenting the prevalence anxiety and depression in COPD patient attending tertiary level hospital. A quantitative cross sectional analytical study was carried out in 221 patients with previously diagnosed COPD. Participants were recruited from respiratory OPD at Tribhuvan University Teaching Hospital, Nepal. Anxiety and depression were screened using previously validated Nepalese version of Hospital Anxiety and Depression Scale (HADS) and dyspnea was assessed using the modified Medical Research Council Dyspnea Scale (mMRC). COPD Assessment Test (CAT) was used to measure the impact of COPD on daily life. Data was analyzed using SPSS version 16. Out of 221, 140 patients (63.3%) had anxiety and 153 patients (69.2%) had depression and 133 (60.2%) had both psychiatric symptoms. Factors associated with anxiety and depression in COPD patients were age, ethnicity, educational status, marital status, current working status, duration of illness, history of previous hospitalization, number of hospitalization in previous year, domiciliary oxygen therapy comorbidities along with dyspnea, CAT score. In conclusion, the study findings suggest that anxiety and depression are highly prevalent in COPD patients.

Assessment of Depression and Anxiety in Chronic Obstructive Pulmonary Disease Patients attending Pulmonary Medicine Department of Rohilkhand Medical College & Hospital, Bareilly, Uttar Pradesh, India

2017 ◽  
Vol 2 (3) ◽  
pp. 137-139
Author(s):  
Preeti Sharma ◽  
Abhishek Kumar ◽  
Arpit Jaiswal ◽  
Chandra S Sharma ◽  
Harsh Rathi ◽  
...  
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Uttar Pradesh ◽  
Anxiety And Depression ◽  
Chronic Obstructive ◽  
Pulmonary Medicine ◽  
Depression And Anxiety ◽  
Obstructive Pulmonary Disease ◽  
Medical College ◽  
Copd Patients

ABSTRACT Introduction Chronic disease like chronic obstructive pulmonary disease (COPD) is associated with various comorbidities. Anxiety and depression are among the common comorbidities and have significant impact on socioeconomic status of the person as well as the course of disease. In our study, we screened COPD patients attending the outpatient department (OPD) of pulmonary medicine for anxiety and depression, using different scales that include questionnaires. About 46.2 and 34.6% cases were found to have depression and anxiety respectively, among all COPD patients (n = 156). Incidence of anxiety and depression was directly proportional to severity of disease. Age, gender, locality, educational, marital, and socioeconomic statuses are some factors that play important roles in the development of these psychiatric comorbidities. Hence, mental assessment of COPD patients should be mandatory with every visit to the OPD. How to cite this article Jaiswal A, Kumar A, Rathi H, Sharma CS, Sharma P, Arya V. Assessment of Depression and Anxiety in Chronic Obstructive Pulmonary Disease Patients attending Pulmonary Medicine Department of Rohilkhand Medical College & Hospital, Bareilly, Uttar Pradesh, India. Int J Adv Integ Med Sci 2017;2(3):137-139.

scholarly journals Anxiety and Depression Among Chronic Obstructive Pulmonary Disease Patients in A Tertiary Care Hospital, Nepal

2018 ◽  
Vol 6 (4) ◽  
pp. 129-135
Author(s):  
Tara Roka ◽  
Nirmala Aryal ◽  
Anjana Ghimire ◽  
Subhadra Pradhan ◽  
Krishna Kumar Aryal
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Tertiary Care Hospital ◽  
Tertiary Care ◽  
Depression Scale ◽  
Anxiety And Depression ◽  
Chronic Obstructive ◽  
Care Hospital ◽  
Cross Sectional ◽  
Obstructive Pulmonary Disease

Background: Psychiatric co-morbidities such as anxiety and depression among patients with chronic obstructive pulmonary disease exacerbate the disease, prolong the hospital stay, increase the disease symptoms and deter the quality of life.Objective: To assess the proportion of anxiety or depression among patients with chronic obstructive pulmonary disease in a tertiary care hospital.Methodology: We carried out a cross sectional study interviewing 307 patients from a tertiary care hospital using sequential sampling technique. We used structured questionnaire and included hospital anxiety and depression scale to measure anxiety and depression. We considered a summed score of

scholarly journals The Prevalence of Liver Diseases among Chronic Obstructive Pulmonary Disease Patients: Statistics from Riyadh, Saudi Arabia

2021 ◽  
pp. 127-135
Author(s):  
Majed Alghamdi ◽  
Bussma Ahmed Bugis ◽  
Alaa Bugis ◽  
Nader Alharbi ◽  
Saleh Mohammed Alotaibi ◽  
...  
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Saudi Arabia ◽  
Liver Disease ◽  
Pulmonary Disease ◽  
Liver Diseases ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Copd Patients ◽  
Alpha 1 Antitrypsin ◽  
Clinical Records

Background: Alpha-1 antitrypsin is an important protein produced by the liver, and deficiency in this protein will cause many liver diseases. A deficiency in this protein can cause congenital emphysema, characterized by damaged and stretched air sacs of the lungs. To our knowledge, limited studies have been performed on liver disease prevalence among chronic obstructive pulmonary disease (COPD) patients in Saudi Arabia. Methods: This study was a secondary data analysis of existing clinical records and aimed at determining the prevalence and association of liver diseases among COPD patients from 2016 to 2020. A total of 1579 clinical records were collected. In this study we analyzed one hundred fifty-five records. Results: Senior patients who were aged 65 or older represented most patients (61.29%). In addition, 81% of the selected COPD patients were diagnosed with cirrhosis, while only one patient was diagnosed with fibrosis. Senior COPD patients aged 65 years or older were more likely to be diagnosed clinically with any type of liver disease (61.75%) than those from younger age groups. Conclusions: Screening and expression tests for patients showing liver and lung diseases are the procedures to determine whether symptoms are due to alpha-1 antitrypsin deficiency. However, this is challenging in patients with COPD.

Sign in / Sign up

Export Citation Format

Share Document